University of Pennsylvania

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count).

1,423 total trials 199 currently recruiting 982 completed early-phase tilt top decile by trial count

University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.

University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.

Top-decile sponsor footprint

University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,423 total, page 14 of 29

COMPLETED

Abbreviated Breast MRI After Cancer Treatment

NCT03664778

TERMINATED Phase 1

NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)

NCT03399448

COMPLETED NA

Prize-linked Savings Initiatives for Promoting Better Health and Economic Outcomes in Kenya

NCT04013295

COMPLETED NA

Connected Health to Decrease Opioid Use in Patients With Chronic Pain

NCT04013529

COMPLETED NA

Prospective Elimination Of Distal Coronary Sinus-Left Atrial Connections for Atrial Fibrillation Ablation Trial

NCT03646643

COMPLETED NA

Neural Response to Food Stimuli: fMRI Changes Following Cognitive Behavioral Therapy for Binge Eating Disorder

NCT03604172

TERMINATED NA

Effects of Sugary Drink Warning Labels

NCT03654586

COMPLETED NA

Prediction Using Connected Technologies for Diabetes

NCT03544320

COMPLETED Phase 3

The Analgesic Efficacy of Protocol for Primary Total Knee Arthroplasty (TKA)

NCT03703206

COMPLETED Phase 2

Furosemide for Accelerated Recovery of Blood Pressure Postpartum

NCT03556761

COMPLETED Phase 4

Overnight Pain Treatment Investigating Opioids vs. Nonopioids

NCT03545893

TERMINATED Phase 2

Pembrolizumab and Itacitinib (INCB039110) for Non-Small Cell Lung Cancer

NCT03425006

TERMINATED NA

Reminders Through Association & Prescription Adherence

NCT03697083

COMPLETED NA

Internet-based CBT After Stroke Pilot

NCT03615079

COMPLETED Early Phase 1

Evaluation of Anti-biofilm Effects of Ferumoxytol (Feraheme) Using an in Situ Biofilm Demineralization Model

NCT03678012

COMPLETED NA

Self-Care for Head and Neck Cancer Survivors With Lymphedema and Fibrosis

NCT03030859

COMPLETED Early Phase 1

Acute Effects of E-Cigarette Aerosol Inhalation

NCT03479203

COMPLETED NA

Remote Monitoring and Social Support for Hypertension Management

NCT03416283

COMPLETED NA

Effect of Omega-3 Fatty Acids on Sleep and Behavior (Pilot Study)

NCT03694314

COMPLETED Phase 2

Targeting Pulsatile Load to Increase Exercise Capacity and Quality of Life After Aortic Valve Replacement for Severe Aortic Stenosis (PULSE AS)

NCT03483051

COMPLETED NA

Immediate Fit Using Innovative Technology Transtibial & Transfemoral Prosthesis

NCT02886936

COMPLETED

Interpolated Flap Study

NCT04164550

COMPLETED

Thermal Camera Detection of Ventriculoperitoneal Shunt Flow

NCT03451669

COMPLETED NA

Psychological Intervention to Reduce Weight Bias Internalization

NCT03572218

COMPLETED NA

Functional Research of Emulsifiers in Humans

NCT03440229

COMPLETED

MRI of Myocardial Infarction

NCT03531151

TERMINATED

Evaluation of the Health and Economic Consequences of Kentucky's Section 1115 Demonstration Waiver

NCT03602456

COMPLETED NA

Reducing HIV Vulnerability Through A Multilevel Life Skills Intervention For Adolescent Men

NCT03155841

COMPLETED NA

Serial SMS Reminders and an Opt-out Mailed FIT Kits to Improve Colorectal Screening Participation: A Single Center RCT

NCT03479645

TERMINATED NA

Impella CP With VA ECMO for Cardiogenic Shock

NCT03431467

COMPLETED Phase 2

Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer

NCT03462342

COMPLETED NA

Comparing Differing Financial Incentive Structures for Increasing Antidepressant Adherence Among Adults

NCT03441399

COMPLETED NA

SMaRT Blood: Single-unit Versus Multiple-unit Packed Red Blood Cell Transfusion in Non-acute Postpartum Anemia

NCT03419780

COMPLETED NA

Neural Basis of Eating Behavior in Abstinent Smokers

NCT03438188

TERMINATED Phase 1

Cerebrovascular Reactivity in American Football Players

NCT03417492

COMPLETED NA

Prehabilitation Intervention to Maximize Early Recovery (PRIMER) in Liver Transplantation

NCT03584646

COMPLETED

Augmented Reality Enhanced Surgery: Use of Holographic Technology in Cranial and Spinal Surgery

NCT03921385

COMPLETED NA

Use of Nudges To Enhance Enrollment in Critical Care Research

NCT03284359

COMPLETED NA

An Open-Trial of Web-Prolonged Exposure (Web-PE) Among Active-Duty Military

NCT03337750

COMPLETED NA

Daytime vs. Delayed Eating Among Obese Individuals

NCT03354169

COMPLETED NA

Automated Hovering for Joint Replacement Surgery

NCT03435549

COMPLETED NA

Diet and Fecal Incontinence in Senior Women

NCT03510052

COMPLETED Phase 1

11C-Trimethoprim PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects

NCT03424525

COMPLETED NA

Prognosticating Outcomes and Nudging Decisions With Electronic Records in the ICU Trial

NCT03139838

COMPLETED NA

Incentivizing Reflection and Output in Exercise

NCT03742778

COMPLETED NA

Enduring Exercise Habits: Trending Norms

NCT03627871

COMPLETED Phase 1

Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based Chemotherapy

NCT03404960

COMPLETED NA

Enduring Exercise Habits

NCT03634423

COMPLETED NA

Incentivizing Planning & Output in Exercising

NCT03742765

COMPLETED NA

Safer Food Allergy Management for Adolescents

NCT03284372

← Previous Page 14 of 29 Next →

Phase Distribution

PhaseTrial count
Phase 1 182
Phase 2 157
Phase 3 43
Phase 4 87

What is open in the University of Pennsylvania pipeline

199 recruiting of 1,423 indexed (14% open); 982 completed (69%).

Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).

Top condition: Obesity (17 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.